Stents, scaffolds and DCB

Alex Sticchi provides his take on the 3-year results of HOST-POLYTECH-ACS RCT which were presented by Hyo-Soo Kim during the ESC 2023 congress in Amsterdam.

Mirvat Alasnag and Pieter C Smits discuss the design of the randomised controlled trial COMPARE-ABSORB and the 5-year results which he presented during the ESC Congress 2023 in Amsterdam.

Claudio Laudani and Daniele Giacoppo report the main results of the ILUMIEN IV trial presented by Ziad Ali, from the St. Francis Hospital, Roslyn, and Clinical Trials Center, Cardiovascular Research Foundation, New York, in a Hot Line session at the European Society of Cardiology congress 2023...

Elad Asher provides his take on the final results of the SHARE (SHort-term Dual Antiplatelet Therapy After Deployment of BioabsoRbable Polymer Everolimus-Eluting Stent) trial, which were presented during the ESC 2023 congress in Amsterdam by Pil-Ki Min.

Quantitative coronary angiography-guidance versus intravascular ultrasound-guidance for drug-eluting stent implantation (GUIDE-DES trial): A multicenter, non-inferiority, randomised-controlled trial

Nicola Ryan provides her take on the final results of GUIDE-DES which were presented by Taeoh Kim during the ESC 2023 congress in Amsterdam.

Note the assumptions in this article are based on the presentation...

Nicola Ryan reports on the BIOFLOW DAPT trial results presented during the ESC 2023 Congress in Amsterdam by Marco Valgimigli and published in Circulation.

BIOFLOW-DAPT is an open-label randomised trial comparing the safety and efficacy of a biodegradable-polymer sirolimus-eluting stent with a durable-polymer zotarolimus-eluting stent in high-bleeding risk patients...

The 12-month outcomes of the BIOMAG-I first-in-human trial demonstrate a favorable safety profile for the third-generation magnesium scaffold and 38 % improved performance compared to its precursor. 

Nieves Gonzalo and Thomas Cuisset join Dejan Milasinovic in the PCR recording studio to share their takeaways from this rich edition of EuroPCR: intracoronary physiology guidance, post-PCI physiology, the increasing use of imaging to improve the clinical outcome of patients, new technologies such as drug-coated balloons,...

What areas are most subject to drug-coated balloon angioplasty in de novo lesions? Fernando Alfonso and Robert Byrne provide some answers in this interview, in which they list the scenarios in which this technology appears attractive.

Small vessel disease, diffuse disease, STEMI, side-branches and patients at high-bleeding risk are...

Check out this session to learn more about polymer-free treatment options with DCB and DES, increasing DCB in the daily cathlab routine, and the possibility of including BRS in the daily PCI routine.